🇺🇸 FDA
Patent

US 7335658

Pyridazine derivatives and their use as therapeutic agents

granted A61KA61K31/00A61K31/501

Quick answer

US patent 7335658 (Pyridazine derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
95
CPC classes
A61K, A61K31/00, A61K31/501, A61K31/551, A61P